Results 11 to 20 of about 18,252,794 (250)
Correlation Between Treatment-Related Adverse Events and Efficacy of Camrelizumab in Combination With Apatinib in Patients With Unresectable Hepatocellular Carcinoma. [PDF]
Cancer MedBackground The relationship between treatment‐related adverse events (TRAEs) and efficacy in patients receiving immune checkpoint inhibitors (ICIs) combined with anti‐angiogenic therapy remains unclear.
Zhang T +6 more
europepmc +2 more sources
Evaluating and Optimising the Retrieval of Research Evidence for Systematic Reviews of Adverse Drug Effects and Adverse Drug Reactions [PDF]
, 2013 Systematic reviews can provide timely, reliable evidence on which to make informed decisions. In order to make balanced decisions, information is not only needed on the benefits of an intervention, but also on its adverse effects.
Golder, Su
core +6 more sources
Frontiers in Oncology, 2021 BackgroundImmune Checkpoint Inhibitors (ICI) have been progressively used in cancer treatment and produced unique toxicity profiles. This systematic review aims to comprehend the patterns and occurrence of treatment-related adverse events (trAEs) based ...
Tao Ouyang +19 more
doaj +1 more source
Safety of Neoadjuvant Immunotherapy in Resectable Cancers: A Meta-Analysis
Frontiers in Immunology, 2022 BackgroundNeoadjuvant immunotherapy has preliminarily been effective in multiple resectable cancers. However, its safety is still largely unknown.MethodsA systematic literature search was conducted in PubMed, Embase, Web of Science, and Cochrane Library ...
Jiawei Xu +6 more
doaj +1 more source
Frontiers in Immunology, 2022 ObjectiveTo study the incidence and distribution of adverse events in immune checkpoint inhibitors (ICI) for digestive system cancers and to provide a reference for the safe, rational, and effective use of immune detection site inhibitors.MethodsWe ...
Liqiu Kou +8 more
doaj +1 more source
The association between adverse events and outcome under checkpoint inhibitors: Where is the deal?
Translational Oncology, 2021 Recent reports have put into evidence the possibility of a link between immune-related adverse events (IRAEs) and treatment outcome, patients drawing a benefit from treatment being also exposed to the risk to develop toxicity.A still unanswered question ...
Gerard Milano +2 more
doaj +1 more source
Psychiatry and Behavioral Sciences, 2021 Objective: The aim of our study is to evaluate treatment related adverse events in children with attention-deficit/ hyperactivity disorder (ADHD) using atomoxetine.
Nurdan Kasar +2 more
doaj +1 more source
Regular treatment with formoterol for chronic asthma: serious adverse events [PDF]
, 2012 Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe ...
Christopher J Cates +3 more
core +1 more source
Treatment-related Adverse events (AEs).
, 2022 Treatment-related Adverse events (AEs).
Hiroaki Shiba (12530426) +10 more
core +1 more source
2 Immune related adverse events in endometrial cancer: a biomarker for treatment efficacy?
Gynecologic Oncology Reports, 2023 Objectives: Immunotherapy (IO), either as single agent or in combination (ex: pembrolizumab +/– lenvatinib), is a critical tool in the treatment of advanced/metastatic endometrial cancer (EC). In other tumor types, the incidence of immune related adverse
Vinita Popat +2 more
doaj +1 more source